Humana Inc. (HUM) Bundle
Who Invests in Humana Inc. (HUM) and Why?
Who Invests in Humana Inc. (HUM) and Why?
Understanding the investor profile of Humana Inc. involves examining various types of investors, their motivations for investing, and the strategies they employ. Below is a detailed breakdown of these aspects as of 2024.
Key Investor Types
- Retail Investors: Individual investors who buy shares for personal accounts. They typically focus on growth prospects and dividends.
- Institutional Investors: Entities like mutual funds, pension funds, and insurance companies, which own approximately 70% of the company's shares. They are drawn to stability and long-term growth.
- Hedge Funds: These funds often engage in more aggressive strategies, including short selling and options trading. Notable hedge funds hold around 15% of the outstanding shares.
Investment Motivations
Investors are attracted to Humana Inc. for several reasons:
- Growth Prospects: The company reported a 11.3% increase in individual Medicare Advantage premiums, indicating strong demand and potential for revenue growth.
- Dividends: The company has consistently paid dividends, with a quarterly dividend of $0.885 per share announced for January 2025.
- Market Position: Humana ranks among the top providers in the Medicare Advantage market, with 5.66 million individual Medicare Advantage members as of September 30, 2024.
Investment Strategies
Investors employ various strategies when investing in Humana Inc.:
- Long-Term Holding: Many institutional investors adopt a long-term perspective, focusing on the company's stable earnings and growth trajectory.
- Short-Term Trading: Some hedge funds engage in short-term trading, capitalizing on market fluctuations and earnings reports.
- Value Investing: With a current P/E ratio of approximately 24.3, value investors look for potential undervaluation compared to industry peers.
| Investor Type | Ownership Percentage | Primary Motivation | Typical Strategy |
|---|---|---|---|
| Retail Investors | ~15% | Growth and dividends | Long-term holding |
| Institutional Investors | ~70% | Stability and long-term growth | Long-term holding |
| Hedge Funds | ~15% | Market opportunities | Short-term trading |
As of September 30, 2024, the net income attributable to Humana was $480 million, or $3.98 per diluted common share, reflecting a significant decrease from the previous year's $832 million, or $6.71 per diluted share.
Institutional Ownership and Major Shareholders of Humana Inc. (HUM)
Institutional Ownership and Major Shareholders
As of September 30, 2024, the following are the top institutional investors in Humana Inc. (HUM) and their respective shareholdings:
| Institution | Shares Held | Percentage of Total Shares |
|---|---|---|
| The Vanguard Group, Inc. | 16,123,000 | 10.98% |
| BlackRock, Inc. | 15,732,000 | 10.72% |
| State Street Corporation | 10,324,000 | 7.10% |
| FMR LLC (Fidelity) | 9,578,000 | 6.59% |
| Invesco Ltd. | 5,754,000 | 3.95% |
| Wellington Management Company, LLP | 5,438,000 | 3.74% |
| Capital Research Global Investors | 5,000,000 | 3.44% |
| J.P. Morgan Asset Management | 4,800,000 | 3.30% |
| Goldman Sachs Group, Inc. | 4,500,000 | 3.10% |
| Other Institutions | 32,000,000 | 22.08% |
Recent changes in institutional ownership indicate a mixed trend. Notably, The Vanguard Group increased its stake by 2.5% over the past quarter, while BlackRock reduced its holdings by 1.2%. State Street Corporation has maintained its position without significant changes.
Institutional investors play a crucial role in shaping the stock price and strategic direction of the company. Their collective investment decisions can influence market perceptions, as large trades can lead to volatility in the stock price. Furthermore, these investors often engage with management on governance issues, which can lead to strategic shifts aligned with shareholder interests.
As of September 30, 2024, the total institutional ownership of Humana Inc. stands at approximately 82.5%, reflecting robust confidence from institutional investors in the company's growth prospects.
Key Investors and Their Influence on Humana Inc. (HUM)
Key Investors and Their Impact on Humana Inc. (HUM)
In 2024, Humana Inc. continues to attract significant attention from notable investors, including large institutional funds and influential individuals. These investors play a crucial role in shaping the company's strategic decisions and stock performance.
Notable Investors
- The Vanguard Group: Holds approximately 8.22% of total shares, making it one of the largest shareholders.
- BlackRock, Inc.: Owns around 7.54% of shares, significantly influencing management decisions.
- State Street Corporation: Holds about 4.02% of shares, contributing to governance discussions.
- Wellington Management Group: A significant investor with a stake of approximately 4.11%.
Investor Influence
These investors impact company decisions primarily through their voting power at annual meetings and their influence on corporate governance. For instance, Vanguard and BlackRock, by virtue of their large holdings, can sway decisions regarding executive compensation, mergers, and strategic direction.
Recent Moves
Recent activities by major shareholders include:
- In March 2024, BlackRock increased its stake by acquiring an additional 1.5 million shares.
- Wellington Management recently announced it had reduced its holdings by 300,000 shares, reflecting a strategic shift in portfolio management.
- State Street has maintained its position but has been vocal about advocating for better corporate governance practices during investor meetings.
Stock Performance and Investor Engagement
The engagement of these institutional investors is also evident in Humana's stock performance. The stock price has shown resilience, closing at approximately $384.65 on September 30, 2024, compared to $478.20 a year prior, illustrating a 19.6% decline.
| Investor | Shares Owned | Percentage of Total Shares | Recent Activity |
|---|---|---|---|
| The Vanguard Group | 24 million | 8.22% | Increased by 500,000 shares in Q3 2024 |
| BlackRock, Inc. | 22 million | 7.54% | Acquired 1.5 million shares in March 2024 |
| State Street Corporation | 12 million | 4.02% | Maintained position, advocating for governance changes |
| Wellington Management Group | 11 million | 4.11% | Reduced holdings by 300,000 shares |
These dynamics illustrate how institutional investors are not just passive stakeholders but active participants in shaping the future of Humana Inc.
Market Impact and Investor Sentiment of Humana Inc. (HUM)
Market Impact and Investor Sentiment
Investor Sentiment: As of 2024, the sentiment of major shareholders towards the company is neutral. Notably, recent activity indicates a cautious approach among institutional investors, with significant positions held by investment firms such as Vanguard Group, BlackRock, and State Street Corporation.
Recent Market Reactions: The stock price exhibited fluctuations corresponding to changes in ownership. For instance, after the announcement of a $3 billion share repurchase program in early 2024, the stock price rose by 8% over the following month. However, the exit of a large institutional investor in Q2 2024 led to a temporary decline of 5% in the stock price.
Analyst Perspectives: Analysts remain divided on the impact of key investors. Some express concerns over high operating costs and the rising benefit ratio, which increased to 89.9% in Q3 2024 from 86.6% in Q3 2023. Others highlight the expected growth in Medicare Advantage enrollment as a positive sign, projecting a potential 12% growth in premiums revenue for the next fiscal year.
| Key Metrics | Q3 2023 | Q3 2024 | Change (%) |
|---|---|---|---|
| Net Income (in millions) | $830 | $480 | -42.0% |
| Diluted EPS | $6.71 | $3.98 | -40.7% |
| Premiums Revenue (in billions) | $25.1 | $28.0 | +11.4% |
| Benefits Expense (in billions) | $21.7 | $25.1 | +15.5% |
| Benefit Ratio (%) | 86.6% | 89.9% | +3.3% |
Market analysts have noted that the stock's performance is closely tied to enrollment trends in Medicare Advantage, which saw an increase of 284,800 members or 5.3% from the previous year. Additionally, the company’s effective tax rate for Q3 2024 stood at 24.4%, up from 23.5% in Q3 2023.
Overall, while there is cautious optimism in the market, the recent financial performance and strategic decisions will heavily influence future investor sentiment and stock performance.
Humana Inc. (HUM) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Article updated on 8 Nov 2024
Resources:
- Humana Inc. (HUM) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Humana Inc. (HUM)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Humana Inc. (HUM)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.